Skip to main content
. 2010 Jul 7;2010(7):CD002839. doi: 10.1002/14651858.CD002839.pub2

Saxena 1999 50 mg.

Methods As for Saxena 1999 25 mg
Participants  
Interventions  
Outcomes
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation? Low risk Probably done
Allocation concealment? Unclear risk Unclear from publications
Blinding? High risk Study was single‐blinded because of the prominent colour of the drug and the difficulty in manufacturing a proper placebo
Completeness of follow‐up Unclear risk Unclear from publications